Azur, Sherryl .
HRN: 05-03-46 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/20/2025
CEFUROXIME 1.5GM (VIAL)
10/21/2025
10/21/2025
IV
1.5 G
PTOR
For D&C
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes